Biomaterial Database

Doxepin in the treatment of psychoneurotic inpatients. 1971

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009497	Neurotic Disorders	Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.	Neuroses,Psychoneuroses,Disorder, Neurotic,Disorders, Neurotic,Neurotic Disorder
D002707	Chlordiazepoxide	An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.	Methaminodiazepoxide,7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide,7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide,Chlordiazepoxide Hydrobromide,Chlordiazepoxide Hydrochloride,Chlordiazepoxide Monohydrochloride,Chlordiazepoxide Perchlorate,Chlozepid,Elenium,Librium,7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide,7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide,Hydrobromide, Chlordiazepoxide,Hydrochloride, Chlordiazepoxide,Monohydrochloride, Chlordiazepoxide,Perchlorate, Chlordiazepoxide
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D003990	Dibenzoxepins
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293	Adolescent	A person 13 to 18 years of age.	Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Doxepin in the treatment of psychoneurotic patients.

April 1970, Current therapeutic research, clinical and experimental,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients.

February 1972, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients.

August 1972, International journal of clinical pharmacology, therapy and toxicology,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.

April 1970, Current therapeutic research, clinical and experimental,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Doxepin in the treatment of psychoneurotic patients: a comparison between two clinical settings.

February 1971, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Doxepin in a single bedtime dose in psychoneurotic outpatients.

October 1974, Archives of general psychiatry,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Bromazepam versus diazepam in psychoneurotic inpatients.

January 1975, Pharmakopsychiatrie, Neuro-Psychopharmakologie,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

A controlled comparative study of doxepin and chlordiazepoxide in psychoneurotic anxiety.

January 1971, The Journal of clinical pharmacology and new drugs,

C Sterlin, and R Oliveros, and T A Ban, and L Jarrold

Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.

July 1981, The Journal of clinical psychiatry,